A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subjects with Advanced Solid Tumors

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513860-25-00

Acronym

222730

Enrollment

135

Registered

2024-10-22

Start date

2024-12-10

Completion date

Unknown

Last updated

2026-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Neoplasms

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Finland, France, Italy, Netherlands, Spain, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026